Unlike the acquired type, hereditary angioedema is bradykinin-mediated only and is mostly caused by mutations to C1 inhibitor (C1INH), which, through the complement pathway, leads to low C4 levels and eventually uninhibited bradykinin. This evidence concerns the gene KNG1 and hereditary angioedema.